Iasis Molecular Sciences INC.

Spokane, WA · Medtech · Private

Antimicrobial composite paints and epoxy flooring incorporating novel copper-based ion exchange biocides for hospital surfaces

Grants
$2.2M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · FAST? Complementary Disinfection for the Healthcare Environment$225,000
Federal grantDepartment of Health and Human Services · Phase I · FAST? Complementary Disinfection for the Healthcare Environment$225,000
Federal grantDepartment of Health and Human Services · Phase I · Development of SupraGuard ETT, A Next Generation Composite Endotracheal Tube for the Prevention of Ventilator-Associated Pneumonia$225,135
Federal grantDepartment of Health and Human Services · Phase I · Development of SupraGuard ETT, A Next Generation Composite Endotracheal Tube for the Prevention of Ventilator-Associated Pneumonia$225,135
Federal grantDepartment of Health and Human Services · Phase II · Clinical Ecosystem Surfaces for Improved Disinfection Outcomes and the Prevention of HAI Transmission$686,990
Federal grantDepartment of Health and Human Services · Phase II · Clinical Ecosystem Surfaces for Improved Disinfection Outcomes and the Prevention of HAI Transmission$578,861
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2138WI-SENSE LLC——
2139IMMUNICOM, INC.——
2140Embark Medical——
2141Iasis Molecular Sciences INC.——
2142VESAREX LLC——
2143ADAPT DESIGN WORKS, LLC——
2144MS2 Array, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Antimicrobial And Biologically Active Polymer Composites And Related Methods, Materials, Coatings And Devicesapplication
  • Antimicrobial And Biological Active Polymer Composites And Related Methods, Materials And Devicesapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.